Open access · CC-BY
via OpenAlex
Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy
Annalisa Lattanzi, Camilla Salvagno, Claudio Maderna, Fabrizio Benedicenti, Francesco Morena, Willem Kulik, Luigi Naldini, Eugenio Montini, Sabata Martino, Angela Gritti
Human Molecular Genetics · 2014 · ▲ 58 citations
Abstract
Globoid cell leukodystrophy (GLD) is an inherited lysosomal storage disease caused by β-galactocerebrosidase (GALC) deficiency. Gene therapy (GT) should provide rapid, extensive and lifetime GALC supply in central nervous system (CNS) tissues to prevent or halt irreversible neurologic progression. Here we used a lentiviral vector (LV) to transfer a functional GALC gene in the brain of Twitcher mice, a severe GLD model. A single injection of LV.GALC in the external capsule of Twitcher neonates resulted in robust transduction of neural cells with minimal and transient activation of inflammatory and immune response. Importantly, we documented a proficient transduction of proliferating and post-mitotic oligodendroglia, a relevant target cell type in GLD. GALC activity (30-50% of physiological levels) was restored in the whole CNS of treated mice as early as 8 days post-injection. The early and stable enzymatic supply ensured partial clearance of storage and reduction of psychosine levels, translating in amelioration of histopathology and enhanced lifespan. At 6 months post-injection in non-affected mice, LV genome persisted exclusively in the injected region, where transduced cells overexpressed GALC. Integration site analysis in transduced brain tissues showed no aberrant clonal expansion and preferential targeting of neural-specific genes. This study establishes neonatal LV-mediated intracerebral GT as a rapid, effective and safe therapeutic intervention to correct CNS pathology in GLD and provides a strong rationale for its application in this and similar leukodystrophies, alone or in combination with therapies targeting the somatic pathology, with the final aim of providing an effective and timely treatment of these global disorders.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/hmg/ddu034
- Canonical
- link ↗
- Fetched
- 2026-07-07 MST
Cite this
APA
Lattanzi, A., Salvagno, C., Maderna, C., Benedicenti, F., Morena, F., Kulik, W., Naldini, L., Montini, E., Martino, S., & Gritti, A. (2014). Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy. <em>Human Molecular Genetics</em>. https://doi.org/10.1093/hmg/ddu034
Vancouver
Lattanzi A, Salvagno C, Maderna C, Benedicenti F, Morena F, Kulik W, et al. Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy. Human Molecular Genetics. 2014. doi:10.1093/hmg/ddu034.
BibTeX
@article{annalisa2014Therap,
title = {Therapeutic benefit of lentiviral-mediated neonatal intracerebral gene therapy in a mouse model of globoid cell leukodystrophy},
author = {Annalisa Lattanzi and Camilla Salvagno and Claudio Maderna and Fabrizio Benedicenti and Francesco Morena and Willem Kulik and Luigi Naldini and Eugenio Montini and Sabata Martino and Angela Gritti},
journal = {Human Molecular Genetics},
year = {2014},
doi = {10.1093/hmg/ddu034},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Stem Cells 2011
Open access · OA
Neural Stem Cell Gene Therapy Ameliorates Pathology and Function in a Mouse Model of Globoid Cell Leukodystrophy
Biochemical and Biophysical Research Communications 2017
Open access · CC-BY
The anti-aging protein Klotho is induced by GABA therapy and exerts protective and stimulatory effects on pancreatic beta cells
Stem Cell Reports 2020
Open access · CC-BY
In Vivo Reprogramming Ameliorates Aging Features in Dentate Gyrus Cells and Improves Memory in Mice
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 2020
Preprint · OA
Faculty Opinions recommendation of Young blood plasma reduces Alzheimer's disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice.
Alzheimer s Research & Therapy 2020
Open access · CC-BY
Young blood plasma reduces Alzheimer’s disease-like brain pathologies and ameliorates cognitive impairment in 3×Tg-AD mice
Rejuvenation Research 2003
Citation only